• No results found

Bendamustine plus rituximab for chronic cold agglutinin disease:

N/A
N/A
Protected

Academic year: 2022

Share "Bendamustine plus rituximab for chronic cold agglutinin disease:"

Copied!
6
0
0

Laster.... (Se fulltekst nå)

Fulltekst

Referanser

RELATERTE DOKUMENTER

Cell signalling downstream of the BCR is aberrantly activated in the B cell malignancy chronic lymphocytic leu- kaemia (CLL), supporting the pathophysiology of the disease.

Suboptimal HL in people with chronic conditions such as asthma, diabetes and chronic obstructive pulmonary disease is reported to be associated with limited disease knowledge,

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease... S- Kreatinin: 130 µmol/L

Background/purpose: Chronic hypercapnic respiratory failure (CHRF) is associated with increased mortality in patients with chronic obstructive pulmonary disease (COPD), and

 Vascular  calcification  in   chronic  kidney  disease:  Pathogenesis  and   clinical

chronic obstructive pulmonary disease; CRSsNP: chronic rhinosinusitis without nasal

Assessment of bone marrow toxicity estimated by white blood cell counts (a) and platelet counts (b) as a function of time after administration of NaCl, cold trastuzumab, and 200,

Cell signalling downstream of the BCR is aberrantly activated in the B cell malignancy chronic lymphocytic leu- kaemia (CLL), supporting the pathophysiology of the disease.